Compliance management programmes
Financial returns for programmes
Customer: |
Bigpharma PLC |
Drug: |
New drug treating patients with high blood cholesterol |
Annual cost per patient: |
£610 |
Annual lapse in compliance
without compliance programme: |
37% |
Number of patients: |
15,000 |
Annual lapse in compliance
with compliance programme: |
20% (17% improvement) |
Total gross improvement
in annual revenue: |
£1.83 million |
Typical cost of
compliance programme: |
(£0.7 million) |
Total net improvement
in profit: |
£1.13 million |
The financial benefits derived from the programme are obvious. The potential ROI stands at 300% or more, and the patient also benefits from better care.
For further information on our compliance services contact us at: compliance@outcometechnologies.com
Compliance page 1 2 3
|
